GetTopicDetailResponse(id=175b4850181, topicName=帕瑞肽, introduction=帕瑞肽, content=null, image=null, comments=5, allHits=1110, url=https://h5.medsci.cn/topic?id=48501, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=8863, tagList=[TagDto(tagId=8863, tagName=帕瑞肽)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2052783, encodeId=01682052e83a3, content=<a href='/topic/show?id=175b4850181' target=_blank style='color:#2F92EE;'>#帕瑞肽#</a>, objectTitle=JAMA Surg：帕瑞肽 vs氫化可的松用于;胰腺切除術(shù)并發(fā)癥的預(yù)防, objectType=article, longId=188306, objectId=da0a18830688, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da0a18830688, replyNumber=0, likeNumber=127, createdTime=2020-06-11, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da0a18830688, moduleTitle=JAMA Surg：帕瑞肽 vs氫化可的松用于;胰腺切除術(shù)并發(fā)癥的預(yù)防, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=da0a18830688)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052781, encodeId=b1822052e81cc, content=<a href='/topic/show?id=175b4850181' target=_blank style='color:#2F92EE;'>#帕瑞肽#</a>, objectTitle=Lancet Oncol：依維莫司、帕瑞肽、依維莫司聯(lián)合帕瑞肽對肺類癌的療效評價, objectType=article, longId=118966, objectId=32671189663e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32671189663e, replyNumber=0, likeNumber=84, createdTime=2018-08-13, rootId=0, userName=仁者大醫(yī), userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32671189663e, moduleTitle=Lancet Oncol：依維莫司、帕瑞肽、依維莫司聯(lián)合帕瑞肽對肺類癌的療效評價, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=32671189663e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052782, encodeId=225e2052e8296, content=<a href='/topic/show?id=175b4850181' target=_blank style='color:#2F92EE;'>#帕瑞肽#</a>, objectTitle=JCEM：帕瑞肽或成為生長抑素和培維索孟治療肢端肥大的替代選擇, objectType=article, longId=120426, objectId=8e11120426bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e11120426bb, replyNumber=0, likeNumber=77, createdTime=2018-10-24, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e11120426bb, moduleTitle=JCEM：帕瑞肽或成為生長抑素和培維索孟治療肢端肥大的替代選擇, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8e11120426bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052780, encodeId=908b2052e800b, content=<a href='/topic/show?id=175b4850181' target=_blank style='color:#2F92EE;'>#帕瑞肽#</a>, objectTitle=Lancet Diabetes Endo：帕瑞肽可有效控制庫欣氏病患者癥狀, objectType=article, longId=115977, objectId=54331159e7cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54331159e7cd, replyNumber=0, likeNumber=97, createdTime=2018-07-19, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54331159e7cd, moduleTitle=Lancet Diabetes Endo：帕瑞肽可有效控制庫欣氏病患者癥狀, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=54331159e7cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2052779, encodeId=79a42052e7909, content=<a href='/topic/show?id=175b4850181' target=_blank style='color:#2F92EE;'>#帕瑞肽#</a>, objectTitle=FDA批準(zhǔn)帕瑞肽治療庫欣病, objectType=article, longId=13126, objectId=a408131269d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a408131269d, replyNumber=0, likeNumber=105, createdTime=2013-10-02, rootId=0, userName=zxxiang, userId=2f5a410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a408131269d, moduleTitle=FDA批準(zhǔn)帕瑞肽治療庫欣病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a408131269d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
